37
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Prevalence of hospitalized women at high-risk for developing lung cancer

ORCID Icon, ORCID Icon & ORCID Icon
Pages 750-754 | Received 27 Feb 2023, Accepted 28 Sep 2023, Published online: 05 Oct 2023

References

  • Toumazis I, Bastani M, Han SS, et al. Risk-based lung cancer screening: a systematic review. Lung Cancer. 2020 Sep;147:154–186. PMID: 32721652. doi: 10.1016/j.lungcan.2020.07.007
  • Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023 Jan;73(1):17–48. PMID: 36633525. doi: 10.3322/caac.21763
  • Jemal A, Ma J, Rosenberg PS, et al. Increasing lung cancer death rates among young women in southern and midwestern States. J Clin Oncol. 2012 Aug 1;30(22): 2739–2744. PMID: 22734032; PMCID: PMC3402885. doi: 10.1200/JCO.2012.42.6098
  • Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395–409. PMID: 21714641; PMCID: PMC4356534.
  • de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–513. PMID: 31995683. doi: 10.1056/NEJMoa1911793
  • Moyer VA. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 160(5): PMID: 24378917:330–338. 2014 Mar 4. doi: 10.7326/M13-2771
  • Lowry KP, Gazelle GS, Gilmore ME, et al. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: a decision analysis. Cancer. 2015;121(10):1556–1562. PMID: 25652107; PMCID: PMC4492436. doi: 10.1002/cncr.29225
  • Katki HA, Kovalchik SA, Berg CD, et al. Development and validation of risk models to select ever-smokers for CT lung cancer screening. JAMA. 2016;315(21):2300–2311. PMID: 27179989; PMCID: PMC4899131. doi: 10.1001/jama.2016.6255
  • Oudkerk M, Liu S, Heuvelmans MA, et al. Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives. Nat Rev Clin Oncol. 2021;18(3):135–151. PMID: 33046839. doi: 10.1038/s41571-020-00432-6
  • Brownlee AR, Donington JS. Update on lung cancer screening. Semin Respir Crit Care Med. 2020;41(3):447–452. PMID: 32450597. doi: 10.1055/s-0039-3400480
  • Triplette M, Thayer JH, Kross EK, et al. The impact of smoking and screening results on adherence to follow-up in an academic multisite lung cancer screening program. Ann Am Thorac Soc. 2021;18(3):545–547. PMID: 32946282. doi: 10.1513/AnnalsATS.202006-631RL
  • Tanner NT, Brasher PB, Wojciechowski B, et al. Screening adherence in the veterans administration lung cancer screening demonstration project. Chest. 2020;158(4):1742–1752. PMID: 32439505. doi: 10.1016/j.chest.2020.04.063
  • Preventive Services Task Force US, Krist AH, Davidson KW, et al. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(10):962–970. PMID: 33687470. doi: 10.1001/jama.2021.1117
  • Gould MK, Sakoda LC, Ritzwoller DP, et al. Monitoring lung cancer screening use and outcomes at four cancer research network sites. Ann Am Thorac Soc. 2017;14(12):1827–1835. PMID: 28683215; PMCID: PMC5711261. doi: 10.1513/AnnalsATS.201703-237OC
  • Randhawa S, Sferra SR, Das C, et al. Examining gender differences in lung cancer screening. J Community Health. 2020;45(5):1038–1042. PMID: 32323173; PMCID: PMC7725370. doi: 10.1007/s10900-020-00826-8
  • Graham H, Kauffman R, Khaliq W. Colorectal cancer screening prevalence, perceived barriers, and preference for screening colonoscopy among hospitalized women. Turk J Gastroenterol. 2022 Nov;33(11):901–908. PMID: 35946889; PMCID: PMC9797704. doi: 10.5152/tjg.2022.21567
  • Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013 Feb 21;368(8): 728–736. PMID: 23425165; PMCID: PMC3929969. doi: 10.1056/NEJMoa1211776
  • Kinsinger LS, Anderson C, Kim J, et al. Implementation of lung cancer screening in the veterans health administration. JAMA Intern Med. 2017 Mar 1;177(3): 399–406. PMID: 28135352. doi: 10.1001/jamainternmed.2016.9022
  • Toubat O, David EA. A narrative review of lung cancer screening in underserved populations. Curr Chall Thorac Surg. 2023;5:6. PMID: 37064329; PMCID: PMC10103952. doi: 10.21037/ccts-20-173
  • Wernli KJ, Tuzzio L, Brush S, et al. Understanding patient and clinical stakeholder perspectives to improve adherence to lung cancer screening. Perm J. 2021;25(3):1–1. PMID: 35348073; PMCID: PMC8817936. doi: 10.7812/TPP/20.295
  • Reuland DS, Cubillos L, Brenner AT, et al. A pre-post study testing a lung cancer screening decision aid in primary care. BMC Med Inform Decis Mak. 2018 Jan 12;18(1): 5. PMID: 29325548; PMCID: PMC5765651. doi: 10.1186/s12911-018-0582-1
  • Nawaz H, Via C, Shahrokni A, et al. Can the inpatient hospital setting be a golden opportunity to improve colon cancer screening rates in the United States? Health Promot Pract. 2014 Jul;15(4):506–511. PMID: 24440921. doi: 10.1177/1524839913518559
  • Simmons VN, Gray JE, Schabath MB, et al. High-risk community and primary care providers knowledge about and barriers to low-dose computed topography lung cancer screening. Lung Cancer PMID: 28285693. 2017;106:42–49. doi: 10.1016/j.lungcan.2017.01.012
  • Olayinka O, Gnanaraj J, Khaliq W. Hospitalized women’s willingness to pay for inpatient screening colonoscopy. Womens Health Rep (New Rochelle). 2022 Sep 13;3(1):768–773. PMID: 36185070; PMCID: PMC9518799. doi: 10.1089/whr.2022.0014
  • Becker N, Motsch E, Trotter A, et al. Lung cancer mortality reduction by LDCT screening-results from the randomized German LUSI trial. Int J Cancer. 2020;146(6):1503–1513. PMID: 31162856. doi: 10.1002/ijc.32486
  • Horeweg N, Scholten ET, de Jong PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol. 2014;15(12):1342–1350. PMID: 25282284. doi: 10.1016/S1470-2045(14)70387-0
  • Kota KJ, Ji S, Bover-Manderski MT, et al. Lung cancer screening knowledge and perceived barriers among physicians in the United States. JTO Clin Res Rep. 2022;3(7):100331. PMID: 35769389; PMCID: PMC9234709. doi: 10.1016/j.jtocrr.2022.100331
  • Peterson EB, Ostroff JS, DuHamel KN, et al. Impact of provider-patient communication on cancer screening adherence: a systematic review Prev Med. Preventive med. 2016 Dec;93:96–105. PMID: 27687535; PMCID: PMC5518612. doi: 10.1016/j.ypmed.2016.09.034
  • Khaliq W, Siferd C, Kantsiper ME, et al. Capturing the rest: inpatient mammography for nonadherent hospitalized women. Am J Prev Med. 2021 Nov;61(5):709–715. PMID: 34229929. doi: 10.1016/j.amepre.2021.04.026
  • Warner ET, Lathan CS. Race and sex differences in patient provider communication and awareness of lung cancer screening in the health information National Trends survey, 2013-2017. Prev Med. 2019 Jul;124:84–90. PMID: 31054908. doi: 10.1016/j.ypmed.2019.05.001
  • Khaliq W, Visvanathan K, Landis R, et al. Breast cancer screening preferences among hospitalized women. J Womens Health (Larchmt). 2013;22(7):637–642. PMID: 23768020. doi: 10.1089/jwh.2012.4083
  • Khaliq W, Harris CM, Landis R, et al. Hospitalized women’s willingness to pay for an inpatient screening mammogram. Ann Fam Med. 2014;12(6):556–558. PMID: 25384819; PMCID: PMC4226778. doi: 10.1370/afm.1694

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.